Tumour Necrosis Factor-Alpha and Interleukin-2 in Pus Aspirate and Blood in Patients with Amoebic Liver Abscess

Journal of Association of Physicians of India

Volumn 47, Issue 11, 1999, Pages 1065-1067

  Agarwal, S K ^a   Khatri, S ^a   Anuradha, S ^a   Singh, N P ^a   Baveja, U ^b  

^a LOK NAYAK HOSPITAL   (India)

^b NATIONAL INSTITUTE OF COMMUNICABLE DISEASES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD; CELLULAR IMMUNITY; FEMALE; HUMAN; IMMUNOLOGY; INDIA; LIVER; LIVER AMEBIASIS; MACROPHAGE ACTIVATION; MALE; METABOLISM; MIDDLE AGED;

ADULT; FEMALE; HUMANS; IMMUNITY, CELLULAR; INDIA; INTERLEUKIN-2; LIVER; LIVER ABSCESS, AMEBIC; MACROPHAGE ACTIVATION; MALE; MIDDLE AGED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033222389     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. World Health Organization. The World Health Report. Bridging the gaps. Report to the director general, WHO, Geneva. 1995
2. Trissl D. Immunology of E.histolytica in human and animal hosts. Rev Infect Dis 1992; 4 : 1154-84.
3. Denis M, Chadee K. In vitro and in vivo studies of macrophage functions in amoebiasis. Infect Immun 1988; 56 (12) : 3126-31.
4. Denis M, Chadee K. Cytokine activation of murine macrophages for in-vitro killing of entamoeba histolytica trophozoite. Infect Immun 1989; 57 (6) : 1750-6.
5. Mosmann TR, Sad S. The expanding universe of T cell subsets : Th1, Th2 and more. Immunol Today 1996; 17 : 138-46.
6. Sherlock S. The diseases of the liver and bililary systems. 6th Edition, Blackwell Scientific publication, Oxford. 1981; 431-5.
7. Locksley R. Immune responses to protozoa. In clinical immunology - principles and practice, Mosby (Ed). 1996; 1.
8. Reed SL. Amoebiasis : an update. Clin Infect Dis 1992; 14 : 385-93.
9. Campbell D, Chadee K. Interleukin (IL)-2, IL4 and tumour necrosis factor - alpha responses during entamoeba histolytica liver abscess development in gerbils. J Infect Dis 1997; 175 : 1176-83.
10. Lin JY, Seguin R, Keller K, Chadee K. Tumour necrosis factor alpha augments nitric oxide dependent macrophage cytotoxicity against entamoeba histolytica by enhanced expression of the nitric oxide synthase gene. Infect Immun 1994; 62 : 1534-41.
11. Chadee K, Denis M, Keller K. Down regulation of murine lymphocyte responsiveness to mitogens after treatment with antigens of entamoeba histolytica. Parasitol Res 1991; 77 : 572-6.
12. Gupta AK, Agarwal SK, Kaur R. Role of tumour necrosis factor-alpha and interleukin-2 in patients with amoebic liver abscess before and after therapy. J Assoc Phys Ind 1997; 45 : 359-63.
13. Seguin R, Mann BJ, Keller K, Chadee K. Identification of galadherence lectin epitopes of E.histolytica that stimulate tumour necrosis alpha production by macrophages. Proc Natl Acad Sci USA 1996; 92 : 1275-8.
14. Denis M, Keller K, Chadee K. Tumour necrosis factor/cachectin and amoebic liver abscess. Am J Med 1990; 88 : 84-5.
15. Diamenstein T, Klos M, Gold D, Hahn H. Interaction between entamoeba histolytica and immune system 1. mitogenicity of entamoeba histolytica extracts for human peripheral T-lymphocytes. J Immunol 1981; 126 : 1084-6.
16. Mann BJ, Chung CN, Dodson JM. Neutralizing monoclonal antibody epitopes of entamoeba histolytica galactose adhesin map to the cysteine rich extracellular domain of the 170 kilodalton heavy subunit. Immunology 1997; 61 : 1723-8.